Prevention and treatment of pressure ulcers/injuries: The protocol for the second update of the international Clinical Practice Guideline 2019.

Decubitus ulcer Guideline Pressure injury Pressure ulcer Pressure ulceration Prevention Skin Treatment Wounds

Journal

Journal of tissue viability
ISSN: 0965-206X
Titre abrégé: J Tissue Viability
Pays: England
ID NLM: 9306822

Informations de publication

Date de publication:
May 2019
Historique:
received: 10 09 2018
revised: 13 12 2018
accepted: 02 01 2019
pubmed: 20 1 2019
medline: 17 9 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

The European Pressure Ulcer Advisory Panel, the Pan Pacific Pressure Injury Alliance, and the National Pressure Ulcer Advisory Panel are updating the 'Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline' (CPG) in 2019. The aim of this contribution is to summarize and to discuss the guideline development protocol for the 2019 update. A guideline governance group determines and monitors all steps of the CPG development. An international survey of consumers will be undertaken to establish consumer needs and interests. Systematic evidence searches in relevant electronic databases cover the period from July 2013 through August 2018. Risk of bias of included studies will be assessed by two reviewers using established checklists and an overall strength of evidence assigned to the cumulative body of evidence. Small working groups review the evidence available for each topic, review and/or draft the guideline chapters and recommendations and/or good practice statements. Finally, strength of recommendation grades are assigned. The recommendations are rated based on their importance and their potential to improve individual patient outcomes using an international formal consensus process. Major methodological advantages of the current revision are a clear distinction between evidence-based recommendations and good practice statements and strong consumer involvement. The 2019 guideline update builds on the previous 2014 version to ensure consistency and comparability. Methodology changes will improve the guideline quality to increase clarity and to enhance implementation and compliance. The full guideline development protocol can be accessed from the guideline website (http://www.internationalguideline.com/).

Identifiants

pubmed: 30658878
pii: S0965-206X(18)30119-0
doi: 10.1016/j.jtv.2019.01.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

51-58

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Jan Kottner (J)

Charité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Germany; Ghent University, Faculty of Medicine and Health Sciences, Belgium. Electronic address: jan.kottner@charite.de.

Janet Cuddigan (J)

University of Nebraska Medical Center, College of Nursing, Omaha, NE, USA.

Keryln Carville (K)

Silver Chain Group and Curtin University School of Nursing, Midwifery and Paramedicine, Perth, Australia.

Katrin Balzer (K)

University of Lübeck, Nursing Research Unit, Germany.

Dan Berlowitz (D)

Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Hospital, Bedford, USA; Boston University School of Medicine MA, USA.

Susan Law (S)

Princess Margaret Hospital, Hong Kong.

Mary Litchford (M)

CASE Software & Books, Greensboro, USA.

Pamela Mitchell (P)

Christchurch Hospital, New Zealand.

Zena Moore (Z)

Royal College of Surgeons in Ireland, Dublin, Ireland; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Department of Public Health, Faculty of Medicine and Health Sciences, UGent, Ghent University, Belgium; Lida Institute, Shanghai, China; Cardiff University, Cardiff, Wales, United Kingdom.

Joyce Pittman (J)

Indiana University Health Academic Health Center, Indianapolis, IN, USA.

Dominique Sigaudo-Roussel (D)

National Scientific Research Center - University of Lyon 1, UMR, 5305, France; Laboratory of Tissue Biology and Therapeutic Engineering, Lyon, France.

Chang Yee Yee (CY)

Singapore General Hospital, Singapore.

Emily Haesler (E)

Curtin University, School of Nursing, Midwifery and Paramedicine, Australia; LaTrobe University, Australian Centre for Evidence Based Aged Care, School of Nursing and Midwifery, Australia; Australian National University, ANU Medical School, Academic Unit of General Practice, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH